The alpha-subunit of
human chorionic gonadotropin (
hCG-alpha) has previously been found to be expressed in
hyperplasias and tumours of numerous endocrine tissues including all those involved in MEN-I syndrome except the parathyroid glands. In the present immunohistochemical investigation of 86 patients with various states of
hyperparathyroidism, expression of
hCG-alpha by subsets of parathyroid cells was shown in 46 cases (54 per cent) including all states of
hyperparathyroidism investigated: primary
adenoma (n = 34, 44 per cent); uraemic secondary
hyperplasia (n = 34, 53 per cent); MEN-I (n = 13, 77 per cent);
MEN-II (n = 2, 100 per cent); and
parathyroid carcinoma (n = 3, 100 per cent). Although the number of parathyroid cells expressing
hCG-alpha was in general low, the occurrence of numerous immunoreactive cells appeared to be concentrated in primary
adenoma and MEN-I (20 and 33 per cent of positive cases, respectively). No expression was found in ten normal control glands, except for very rare cells in one case. Expression of
hCG-alpha was in part associated with that of
hCG-beta, which appeared to be more commonly expressed than
hCG-alpha in cases of
secondary hyperparathyroidism. In separate experiments, Bouin fixation was found to preserve the immunoreactivity of
hCG-alpha and
hCG-beta better than the
formalin fixation used in this study, suggesting that the figures may be underestimates. These immunohistochemical results are in agreement with a previous biochemical study showing
hCG-alpha and
hCG-beta in extracts of parathyroid tumours and extend to the parathyroid glands the otherwise ubiquitous finding of
hCG-alpha expression in MEN-I-related
neoplasms.